Authors: Henne, KR Fisher, MB Iyer, KR Lang, DH Trager, WF Rettie, AE

Citation: Kr. Henne et al., Active site characteristics of CYP4B1 probed with aromatic ligands, BIOCHEM, 40(29), 2001, pp. 8597-8605

Authors: Fisher, MB VandenBranden, M Findlay, K Burchell, B Thummel, KE Hall, SD Wrighton, SA

Citation: Mb. Fisher et al., Tissue distribution and interindividual variation in human UDP-glucuronosyltransferase activity: relationship between UGT1A1 promoter genotype and variability in a liver bank, PHARMACOGEN, 10(8), 2000, pp. 727-739

Authors: Fisher, MB Campanale, K Ackermann, BL Vandenbranden, M Wrighton, SA

Citation: Mb. Fisher et al., In vitro glucuronidation using human liver microsomes and the pore-formingpeptide alamethicin, DRUG META D, 28(5), 2000, pp. 560-566

Authors: Paine, MF Fisher, MB

Citation: Mf. Paine et Mb. Fisher, Immunochemical identification of UGT isoforms in human small bowel and in Caco-2 cell monolayers, BIOC BIOP R, 273(3), 2000, pp. 1053-1057

Authors: Haining, RL Jones, JP Henne, KR Fisher, MB Koop, DR Trager, WF Rettie, AE

Citation: Rl. Haining et al., Enzymatic determinants of the substrate specificity of CYP2C9: Role of B '-C loop residues in providing the pi-stacking anchor site for warfarin binding, BIOCHEM, 38(11), 1999, pp. 3285-3292

Authors: Rettie, AE Fisher, MB

Citation: Ae. Rettie et Mb. Fisher, Transformation enzymes: Oxidative; Non-P450, HANDBOOK OF DRUG METABOLISM, 1999, pp. 131-151